Jack Nathan Medical Reports Strong Revenue Growth

Jack Nathan Medical (TSE:JNH) has released an update.

Jack Nathan Medical Corp. has reported a robust beginning to fiscal 2025, showcasing a 25% increase in revenue and an expansion to 243 clinic locations. The company’s leadership attributes this growth to strategic efforts in optimizing clinic capacities and expanding services. Despite the rise in operating expenses, the emphasis remains on driving clinic profitability and revenue through operational growth.

For further insights into TSE:JNH stock, check out TipRanks’ Stock Analysis page.